Forbes contributors publish independent expert analyses and insights. The U.S. spent $722.5 billion on pharmaceuticals in 2023. Although brand-name drugs consume four out of every 5 dollars America ...

The Centers for Medicare & Medicaid Services released details of its proposal to address the expensive costs of Medicare Part B.

Below, STAT previews the three key questions that could define a potentially busy year in the worlds of substance use and ...

Generic drugs are cheaper copies of brand drugs, offering significant savings to patients. Once a brand-name drug's patent expires, competitors can apply to make generic versions. Generic ...

The US Food and Drug Administration will take steps to streamline the development of generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to accelerate ...

President Donald Trump announced a new round of tariffs beginning in October 2025 that would impose a 100% duty on brand name drugs imported to the United States. There's a major exemption to the ...

The Trump administration isn't planning to impose tariffs on generic drug imports, The Wall Street Journal reported, although the move isn't final and could change in the coming weeks. "The ...

Philadelphia announced a new lawsuit Tuesday against three major drug manufacturers and three pharmacy benefit managers. The city alleges all six are complicit in an insulin pricing scheme to keep the ...

Big pharmaceutical companies are boosting their production capacity of branded medications with billions of dollars in new U.S. manufacturing plant construction, but generic drug production still ...

Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India's booming obesity drug market ...

Federal health officials are advising consumers that more than 140,000 bottles of cholesterol medication are being recalled due to "failed dissolution specifications." Several bottle sizes of ...